Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancer
Allan LiptonMilton S. Hershey Medical Center, Pennsylvania State University, Hershey, PA, USAAbstract: Bisphosphonates inhibit osteoclast-mediated bone resorption, thereby inhibiting the release of growth factors necessary to promote cancer cell growth, differentiation, and tumor formation in bone....
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2011-03-01
|
| Series: | Breast Cancer: Targets and Therapy |
| Online Access: | http://www.dovepress.com/bones-breasts-and-bisphosphonates-rationale-for-the-use-of-zoledronic--a6703 |